Former Seagen CEO Siegall returns to biotech as head of early-stage startup
BioPharma
Stay updated with breaking news from David Epstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
US pharmaceutical giant Pfizer announced that it had reached a deal to buy biotech firm Seagen.
Pfizer announced Monday it plans to acquire Seagen in an all-cash deal for $43 billion.
Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines, for $229 in cash per Seagen share for a ...
Pfizer's planned $43 billion purchase of Seagen didn't spark the usual huge stock surge, due to antitrust review concerns.